Scheduling determines how that signal is expressed
The fundamental difference we are taking is that where GLP-1 drugs slow down the gut and suppress appetite, our lead therapy, Myo4, works directly on metabolism
Symptoms of GSD1a typically appear between 36 months of age, as feeding intervals lengthen
Lutz Menzel for important discussion and feedback
J Neurosci 31(17):65876594 Hansen HH, Barkholt P, Fabricius K, Jelsing J, Terwel D, Pyke C, Knudsen LB, Vrang N (2016) The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy